Absolute configuration of pentahydroxy bile alcohols excreted by patients with cerebrotendinous xanthomatosis: a circular dichroism study

Absolute configuration of pentahydroxy bile alcohols excreted by patients with cerebrotendinous xanthomatosis: a circular dichroism study

The absolute configurations of the C27 pentahydroxy bile alcohols present in bile and feces of two patients with cerebrotendinous xanthomatosis (CTX) were determined by circular dichroism (CD) spectroscopy. The CD spectra of 5β-cholestane-3α,7α,12α,24α,25-pentol in the presence of Eu(fod)3 [tris(1,1...

Full description

Bibliographic Details
Main Authors:	B Dayal, G Salen, G S Tint, V Toome, S Shefer, E H Mosbach
Format:	Article
Language:	English
Published:	Elsevier 1978-02-01
Series:	Journal of Lipid Research
Subjects:	Cotton effects epimeric bile alcohols
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227520415561

Similar Items

Configuration at C-25 in 5 beta-cholestane-3 alpha,7 alpha,12 alpha,25,26-pentol excreted by patients with cerebrotendinous xanthomatosis: circular dichroism and 13C-NMR studies.
by: B Dayal, et al.
Published: (1990-05-01)

Identification of pentahydroxy bile alcohols in cerebrotendinous xanthomatosis: characterization of 5β-cholestane-3α, 7α, 12α, 24xi, 25-pentol and 5β-cholestane-3α, 7α, 12α, 23xi, 25-pentol
by: S. Shefer, et al.
Published: (1975-07-01)

Metabolism of Cholesterol and Bile Acids by the Gut Microbiota
by: Philippe Gérard
Published: (2013-12-01)

Disrupted coordinate regulation of farnesoid X receptor target genes in a patient with cerebrotendinous xanthomatosis
by: Akira Honda, et al.
Published: (2005-02-01)

Increased plasma bile alcohol glucuronides in patients with cerebrotendinous xanthomatosis: effect of chenodeoxycholic acid
by: A K Batta, et al.
Published: (1987-08-01)

Fine-mapping, mutation analyses, and structural mapping of cerebrotendinous xanthomatosis in U.S. pedigrees
by: Mi-Hye Lee, et al.
Published: (2001-02-01)

Chenodeoxycholic acid normalizes elevated lipoprotein secretion and catabolism in cerebrotendinous xanthomatosis.
by: G S Tint, et al.
Published: (1989-05-01)

Metabolism of potential precursors of chenodeoxycholic acid in cerebrotendinous xanthomatosis (CTX).
by: G Salen, et al.
Published: (1979-01-01)

A newborn screening method for cerebrotendinous xanthomatosis using bile alcohol glucuronides and metabolite ratios[S]
by: Frédéric M. Vaz, et al.
Published: (2017-05-01)

Effect of chenodeoxycholic acid on biliary and urinary bile acids and bile alcohols in cerebrotendinous xanthomatosis; monitoring by high performance liquid chromatography.
by: A K Batta, et al.
Published: (1985-06-01)

Contribution of the 7β-hydroxysteroid dehydrogenase from Ruminococcus gnavus N53 to ursodeoxycholic acid formation in the human colon[S]
by: Ja-Young Lee, et al.
Published: (2013-11-01)

Newborn screening for cerebrotendinous xanthomatosis is the solution for early identification and treatment
by: Andrea E. DeBarber, et al.
Published: (2018-11-01)

Transformation of 5α-cholest-7-en-3β-ol to cholesterol and cholestanol in cerebrotendinous xanthomatosis
by: G.S. Tint, et al.
Published: (1974-05-01)

Occurrence of bile alcohol glucuronides in bile of patients with cerebrotendinous xanthomatosis
by: T Hoshita, et al.
Published: (1980-11-01)

Cerebrotendinous xanthomatosis
by: Mahalakshmi Muniaswamy, et al.
Published: (2016-01-01)

Biosynthesis of cholesterol, lanosterol, and delta 7-cholestenol, but not cholestanol, in cultured fibroblasts from normal individuals and patients with cerebrotendinous xanthomatosis.
by: G S Tint, et al.
Published: (1982-05-01)

A blood test for cerebrotendinous xanthomatosis with potential for disease detection in newborns
by: Andrea E. DeBarber, et al.
Published: (2014-01-01)

Metabolic profiling in serum, cerebrospinal fluid, and brain of patients with cerebrotendinous xanthomatosis
by: Philip Höflinger, et al.
Published: (2021-01-01)

Preparation of 24(R)- and 24(S)-5β-cholestane-3α,7α,24-triols and 25(R)- and 25(S)-5β-cholestane-3α,7α,26-triols by a hydroboration procedure
by: B Dayal, et al.
Published: (1978-02-01)

Case Report: Cerebrotendinous xanthomatosis
by: Amit A Karandikar, et al.
Published: (2009-10-01)

Case Report: Cerebrotendinous xanthomatosis
by: Karandikar Amit, et al.
Published: (2009-01-01)

Cerebrotendinous Xanthomatosis In A Family
by: Chatterjee Gobinda, et al.
Published: (1999-01-01)

Case Report: Early Treatment With Chenodeoxycholic Acid in Cerebrotendinous Xanthomatosis Presenting as Neonatal Cholestasis
by: Irene Degrassi, et al.
Published: (2020-07-01)

Identification of short side chain bile acids in urine of patients with cerebrotendinous xanthomatosis
by: T Kuramoto, et al.
Published: (1990-10-01)

Cerebrotendinous xanthomatosis - A case report
by: Arshed Hussain Parry, et al.
Published: (2019-07-01)

Cerebrotendinous xanthomatosis: Clinical and neuroimaging findings
by: S Sheetal, et al.
Published: (2020-01-01)

A preventable ataxia: Cerebrotendinous xanthomatosis
by: Bhagya Shaji, et al.
Published: (2019-01-01)

Feedback regulation of bile acid biosynthesis in the rat
by: Shefer Sarah, et al.
Published: (1969-11-01)

Contribution of Inhibitory Metabolites and Competition for Nutrients to Colonization Resistance against <i>Clostridioides difficile </i>by Commensal <i>Clostridium</i>
by: Amber D. Reed, et al.
Published: (2021-02-01)

Synthesis and structure of 26 (or 27)-nor-5 beta-cholestane-3 alpha,7 alpha,12 alpha,24S,25 xi-pentol isolated from the urine and feces of a patient with sitosterolemia and xanthomatosis.
by: B Dayal, et al.
Published: (1985-03-01)

Cholic acid biosynthesis: conversion of 5β-cholestane-3α,7α,12α,25-tetrol into 5β-cholestane-3α,7α, 12α,24β,25-pentol by human and rat liver microsomes
by: F W Cheng, et al.
Published: (1977-01-01)

Cerebrotendinous xanthomatosis: A report of 3 cases
by: Katharine Saussy, MD, et al.
Published: (2020-12-01)

Cerebrotendinous xanthomatosis: reduced serum 26-hydroxycholesterol.
by: N B Javitt, et al.
Published: (1982-05-01)

Images in Neurology: Cerebrotendinous Xanthomatosis with Cerebellar Vacuolation
by: Erkingül Shugaiv, et al.
Published: (2013-03-01)

Images in Neurology: Cerebrotendinous Xanthomatosis with Cerebellar Vacuolation
by: Erkingül Shugaiv, et al.
Published: (2013-03-01)

Hepatic 7 alpha-dehydroxylation of bile acid intermediates, and its significance for the pathogenesis of cerebrotendinous xanthomatosis.
by: S Skrede, et al.
Published: (1988-02-01)

Update on newborn dried bloodspot testing for cerebrotendinous xanthomatosis: An available high-throughput liquid-chromatography tandem mass spectrometry method
by: Lisa Bleyle, et al.
Published: (2016-06-01)

SUBSTANTIATION OF SURGICAL APPROACH IN IATROGENIC INJURIES OF THE BILE-EXCRETING DUCTS
by: N. A. Maistrenko, et al.
Published: (2015-10-01)

Clinical and genetic characteristics of Chinese patients with cerebrotendinous xanthomatosis
by: Qing-Qing Tao, et al.
Published: (2019-12-01)

Neuromuscular abnormality and autonomic dysfunction in patients with cerebrotendinous xanthomatosis
by: Huang Chi-Ren, et al.
Published: (2011-05-01)